CE-MRI&CESM in Solid Breast Lesions

NCT04832191 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-04-05

No results posted yet for this study

Summary

Our study aimed to assess the accuracy of CE-SM in comparison to contrast-enhanced breast MRI in the evaluation of solid breast lesions.

Conditions

  • Breast Neoplasms

Interventions

DEVICE

CE-SM

contrast enhanced spectral mammography \&contrast enhanced magnetic resonance imaging

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-04-01
Completion
2023-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04832191 on ClinicalTrials.gov